Arteris Inc
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
AIP$19.09-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In thousands)
| Year ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $(36,869) | $(27,387) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,069 | 2,099 |
| Stock-based compensation | 14,535 | 11,692 |
| Pension plan expenses | 134 | 136 |
| Non-cash operating lease expense | 118 | (21) |
| Amortization of deferred income | (1,179) | (391) |
| Gain on deconsolidation of subsidiary | — | (149) |
| Loss from equity method investment | 3,397 | 284 |
| Net accretion of discounts on available-for-sale securities | (893) | (177) |
| Deferred income taxes | — | (484) |
| Other, net | 10 | 14 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (4,858) | 7,102 |
| Prepaid expenses and other assets | (1,301) | 202 |
| Accounts payable | (389) | (1,034) |
| Accrued expenses and other liabilities | 2,467 | 517 |
| Deferred revenue | 6,030 | 830 |
| Net cash used in operating activities | (15,729) | (6,767) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchases of property and equipment | (1,503) | (1,051) |
| Purchases of available-for-sale securities and other | (47,788) | (35,031) |
| Proceeds from maturities of available-for-sale securities | 44,650 | — |
| Payments relating to investment in equity method investment | — | (519) |
| Proceeds from principal portion of related party loan | — | 241 |
| Payments for business combination, net of cash acquired | — | (1,121) |
| Other | (50) | — |
| Net cash used in investing activities | (4,691) | (37,481) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Payments of contingent consideration for business combination | (1,592) | (1,573) |
| Principal payments under vendor financing arrangements | (1,289) | (1,136) |
| Payments to tax authorities for shares withheld from employees | (607) | (2,065) |
| Proceeds from exercise of stock options | 490 | 876 |
| Payments of deferred offering costs | — | (256) |
| Other | 79 | — |
| Net cash used in financing activities | (2,919) | (4,154) |
| NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (23,339) | (48,402) |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 37,423 | 85,825 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $14,084 | $37,423 |
| Cash, cash equivalents and restricted cash at end of period: | ||
| Cash and cash equivalents | $13,696 | $37,423 |
| Restricted cash, noncurrent | 388 | — |
| Cash, cash equivalents and restricted cash at end of period | $14,084 | $37,423 |
| Supplemental cash flow information: | ||
| Cash paid for taxes | $1,294 | $790 |
| Noncash activities: | ||
| Operating lease right-of-use assets exchanged for lease liabilities | $3,392 | $63 |
| Purchase of property and equipment through vendor financing | $3,319 | $2,088 |
| Equity obtained in equity method investment in exchange for contribution of license agreement (Note 15) | $— | $11,563 |
| Issuance of common stock for business combination | $— | $1,333 |
| Contingent consideration for business combination | $— | $362 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.